Jane Tereszczuk
Papers
1
Total Citations
16
H-Index
1
About
Dr. Jane Tereszczuk is a leading clinical researcher in radiation oncology, with a focused expertise in hypo-fractionated stereotactic body radiation therapy (SBRT) for localized prostate cancer. Her seminal work, the German bi-center single treatment group feasibility trial (2017, 16 citations), pioneered a novel approach to prostate cancer treatment by demonstrating the safety and efficacy of a significantly shortened, non-invasive radiation regimen. This contribution directly addresses the critical patient need for treatments with minimal side effects, challenging the standard 5-to-8-week protocols by compressing therapy into a hypo-fractionated schedule. By rigorously evaluating this technique across two German centers, Dr. Tereszczuk provided foundational evidence that SBRT could maintain tumor control while drastically reducing treatment burden, improving patient quality of life. Her research bridges the gap between conventional external beam radiation therapy and modern, ultra-precise delivery methods, offering a viable, less disruptive alternative for men with localized disease. Dr. Tereszczuk’s work continues to influence clinical guidelines and inspire further investigation into dose-escalation and fractionation optimization in prostate cancer radiotherapy.
Research Focus
Key Achievements
Top Papers
- 1